Stocktoria
Elanco Animal Health Inc ELAN
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-09-20
Elanco Animal Health Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 55.0% | 54.9% | 56.3% | — | — |
| Net margin | -4.9% | 7.6% | -27.9% | -1.8% | -10.1% |
| FCF margin | 6.0% | 8.9% | 3.0% | 6.4% | 6.8% |
| Return on assets | -1.7% | 2.7% | -8.6% | -0.5% | -2.9% |
| Return on equity | -3.5% | 5.5% | -19.8% | -1.1% | -6.4% |
| Debt / equity | 0.57× | 0.71× | 0.93× | 0.80× | 0.84× |
| Current ratio | 2.17 | 2.44 | 2.75 | 1.93 | 1.99 |
| Revenue growth | 6.2% | 0.5% | 0.1% | -7.4% | 45.6% |
Source: SEC EDGAR filings · CIK 0001739104 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.